humans and packaging and labelling€¦ · no pharmaceutical industry funding no conflicts of...
TRANSCRIPT
Humans and Packaging and
Labelling
Michael Hamilton
Institute for Safe Medication Practices Canada
www.ismp-canada.org
ISMP Canada 2017
The Institute for Safe Medication Practices Canada is an
independent not-for-profit organization dedicated to
reducing preventable harm from medications.
Our aim is to heighten awareness of system
vulnerabilities and facilitate system improvements.
www.ismp-canada.org
ISMP Canada 2017
No pharmaceutical industry funding
No conflicts of interest to declare
ISMP Canada 2017
ISMP Canada spends a lot of effort
and energy informing safe packaging
and labelling
Packaging and Labelling is the initial
interface between human and
medicine
8
Type Style and Size
9
10
Colour and Contrast
Colour and Contrast
11
Atropine 1 mg/5 mL (0.2% w/w)
Atropine 0.5 mg/5 mL (0.1% w/w)
Colour and Contrast
12
Colour and Contrast
13
Colour and Contrast
14
Colour and Contrast
15
Colour and Contrast
16
Colour and Contrast
17
Colour and Contrast
18
Expression of Strength
Legacy expressions of strength
19
mg/cartridge 4 mg delivered
Expression of Strength
20
Expression of Strength
25
Expression of Strength
26
Expression of Strength
27
Expression of Strength
28
Abbreviations, Symbols, Dose Designations
29
Abbreviations, Symbols, Dose Designations
30
Unrelated information is not separated with marks that could
be misinterpreted
Proximity and Compatibility
31
Logo, Branding, and Trade Dress
32
Packaging - General Considerations
33
Packaging - Multi-part Products
34
Packaging - Multi-part Products
35
36
Packaging - General Considerations
37
Expiry Date
38
Transdermal Patches
BEFORE AFTER
39
Blister Packaging
40
Paediatric Products
41
42
Thank You!
Michael Hamilton: [email protected]
General Inquiries: [email protected]
ISMP Canada 2017